Inhibition of the BGR-ABL tyrosine kinase for the treatment of chronic myeloid leukemia

被引：0
|
作者：
Coulombel, L [1 ]
机构：
[1] INSERM U474, F-75014 Paris, France
来源：
M S-MEDECINE SCIENCES | 2001年 / 17卷 / 8-9期
关键词：
D O I：
10.4267/10608/2038
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：952 / 953
页数：2
相关论文
共 50 条
  • [11] Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia
    Lee, Hyewon
    Basso, Igor Novitzky
    Kim, Dennis Dong Hwan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 632 - 641
  • [12] The Role of Hypoxia on ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells
    Okabe, Seiichi
    Tanaka, Yuko
    Moriyama, Mitsuru
    Gotoh, Akihiko
    BLOOD, 2019, 134
  • [13] Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia
    Hyewon Lee
    Igor Novitzky Basso
    Dennis Dong Hwan Kim
    International Journal of Hematology, 2021, 113 : 632 - 641
  • [14] Monitoring patients with chronic myeloid leukemia receiving Abl tyrosine kinase inhibitor therapy
    Oehler, Vivian
    Radich, Jerald P.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S58 - S63
  • [15] Predictors of tyrosine kinase inhibitor treatment for chronic myeloid leukemia
    Cole, Ashley L.
    Wood, William A.
    Muluneh, Benyam
    Lund, Jennifer L.
    Lafata, Jennifer Elston
    Dusetzina, Stacie B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 104 - 105
  • [16] New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
    Kimura, Shinya
    Ashihara, Eishi
    Maekawa, Taira
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (05) : 371 - 379
  • [17] BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
    An, Xin
    Tiwari, Amit K.
    Sun, Yibo
    Ding, Pei-Rong
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1255 - 1268
  • [18] SYNTHESES AND PROPERTIES OF DRUGS INHIBITORS OF BCR-ABL TYROSINE KINASE, USED IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
    de Azevedo, Liviane D.
    Bastos, Monica M.
    de Oliveira, Andressa Paula
    Boechat, Nubia
    QUIMICA NOVA, 2017, 40 (07): : 791 - 809
  • [19] ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition
    Perna, Fabiana
    Abdel-Wahab, Omar
    Levine, Ross L.
    Jhanwar, Suresh C.
    Imada, Kazunori
    Nimer, Stephen D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 342 - 343
  • [20] ABL Kinase Domain Mutations in Iranian Chronic Myeloid Leukemia Patients with Resistance to Tyrosine Kinase Inhibitors
    Shojaei, Mahboobeh
    Rezvani, Hamid
    Azarkeivan, Azita
    Poopak, Behzad
    LABORATORY MEDICINE, 2021, 52 (02) : 158 - 167
12345